摘要
分析了对复发性流产使用低分子肝素联合小剂量阿司匹林的临床效果。抽取2020年4月—2021年4月期间廊坊广安医院收治的104例复发性流产患者作为研究对象,采取随机数字表法将其分为对照组和研究组,其中对照组52例患者使用小剂量阿司匹林治疗,研究组52例患者使用低分子肝素联合小剂量阿司匹林治疗。通过对比两组患者凝血4项指标(PLT、APTT、TT、FIB)、D-二聚体(D-D)、纤维蛋白降解产物(FDP)、妊娠结局(先兆流产、流产、早产、足月妊娠)以及不良反应发生情况,发现低分子肝素联合小剂量阿司匹林治疗复发性流产效果显著且安全性较好。
To analyze the clinical effect of low-molecular-weight heparin plus low-dose aspirin on recurrent abortion.104 patients with recurrent abortion who were admitted to Langfang Cross Hospital from April 2020 to April 2021 were selected as the research objects.They were randomly divided into the control group and the study group by using the random number table.Among them,52 patients in the control group were treated with low-dose aspirin,and 52 patients in the study group were treated with low-molecular-weight heparin combined with low-dose aspirin.By comparing the four coagulation indicators(PLT,APTT,TT,FIB),D-dimer(D-D),fibrin degradation products(FDP),pregnancy outcomes(threatened abortion,abortion,premature delivery,term pregnancy)and adverse reactions of the two groups of patients.It was found that low-molecular-weight heparin combined with low-dose aspirin was effective and safe in the treatment of recurrent abortion.
作者
武俊颖
WU Junying(Langfang Cross Hospital,Langfang,Hebei 065000)
出处
《科技与健康》
2022年第11期87-89,共3页
Technology and Health
关键词
低分子肝素
阿司匹林
复发性流产
妊娠结局
凝血4项
low molecular weight heparin
aspirin
recurrent abortion
pregnancy outcome
4 items of blood coagulation
